相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S. Chheda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
Chloe Chong et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
Sylvain Simon et al.
ONCOIMMUNOLOGY (2018)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
Thierry Conroy et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer
Amritha Nair et al.
NATURE MEDICINE (2018)
Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer
Sara Bobisse et al.
NATURE COMMUNICATIONS (2018)
From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer
Andres Munoz Martin et al.
JOURNAL OF CANCER (2018)
Pancreatic Ductal Adenocarcinoma: A Strong imbalance of Good and Bad immunological Cops in the Tumor Microenvironment
Etienne D. Foucher et al.
FRONTIERS IN IMMUNOLOGY (2018)
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study
Lei Huang et al.
BMC MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Predicting Antigen Presentation - What Could We Learn From a Million Peptides?
David Gfeller et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands
David Gfeller et al.
JOURNAL OF IMMUNOLOGY (2018)
Noncoding regions are the main source of targetable tumor-specific antigens
Celine M. Laumont et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
Wouter W. van Willigen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunotherapy for pancreatic cancer: Barriers and breakthroughs
Robert J. Torphy et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients
Motoki Miyazawa et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Immunotherapy in pancreatic cancer treatment: a new frontier
Komal Thind et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Phase I study of nivolumab (nivo) plus nab-paclitaxel (nab-P) ± gemcitabine (Gem) in solid tumors: Interim results from the pancreatic cancer (PC) cohorts.
Zev A. Wainberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
Michael S. Khodadoust et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
Michal Bassani-Sternberg et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
'Hotspots' of antigen presentation revealed by Human Leukocyte antigen Ligandomics for neoantigen prioritization
Markus Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Results of a randomized phase II study investigating multipeptide vaccination with IMA901 in advanced renal cell carcinoma (RCC).
C. Reinhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
What treatment in 2017 for inoperable pancreatic cancers?
J. Taieb et al.
ANNALS OF ONCOLOGY (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Massimo Andreatta et al.
BIOINFORMATICS (2016)
Personalized approaches to active immunotherapy in cancer
Eran Ophir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol et al.
CLINICAL CANCER RESEARCH (2016)
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
Oezlem Tuereci et al.
CLINICAL CANCER RESEARCH (2016)
MHC class I-associated peptides derive from selective regions of the human genome
Hillary Pearson et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions
Michal Bassani-Sternberet et al.
JOURNAL OF IMMUNOLOGY (2016)
Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients
Steve Boudewijns et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells
Vikash J. Bhagwandin et al.
PLOS ONE (2016)
Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames
Celine M. Laumont et al.
NATURE COMMUNICATIONS (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Shelly Kalaora et al.
ONCOTARGET (2016)
Pancreatic Ductal Adenocarcinoma
Megan B. Wachsmann et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Peter Bailey et al.
SCIENTIFIC REPORTS (2016)
Systemic treatment with anti-PD-1 antibody nivolumab in combination with vaccine therapy in advanced pancreatic cancer
Jan Nesselhut et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
Shuhei Mayanagi et al.
CANCER SCIENCE (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Checkpoint blockade in combination with cancer vaccines
Michael A. Morse et al.
VACCINE (2015)
Perspectives in the treatment of pancreatic adenocarcinoma
Angel Cid-Arregui et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
Martin Wartenberg et al.
ONCOTARGET (2015)
Mutational profiling of colorectal cancers with microsatellite instability
Elaine I. Lin et al.
ONCOTARGET (2015)
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
Kevin C. Soares et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors
Juan Fu et al.
CANCER RESEARCH (2014)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci et al.
CELL DEATH AND DIFFERENTIATION (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy
Amedeo Amedei et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays
Nilanjana Tewari et al.
BMC CANCER (2013)
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Y. Ino et al.
BRITISH JOURNAL OF CANCER (2013)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
IntOGen-mutations identifies cancer drivers across tumor types
Abel Gonzalez-Perez et al.
NATURE METHODS (2013)
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
Jorg J. A. Calis et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized Trials
Edward J. Mills et al.
AMERICAN JOURNAL OF MEDICINE (2012)
A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer
Yefei Rong et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2012)
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Suzanne L. Topalian et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
GENCODE: The reference human genome annotation for The ENCODE Project
Jennifer Harrow et al.
GENOME RESEARCH (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
Clinical and Immunologic Evaluation of Dendritic Cell-Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
Yukino Kimura et al.
PANCREAS (2012)
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
Jordan M. Winter et al.
PLOS ONE (2012)
The role of the tumor endothelium in leukocyte recruitment in pancreatic cancer
Jan Schmidt et al.
SURGERY (2012)
A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data
Heng Li
BIOINFORMATICS (2011)
Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence
Carmen Guerra et al.
CANCER CELL (2011)
Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity
Sophie R. Sierro et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
The UCSC Genome Browser database: update 2011
Pauline A. Fujita et al.
NUCLEIC ACIDS RESEARCH (2011)
Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
Andreas Draube et al.
PLOS ONE (2011)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
HER2 overexpression correlates with survival after curative resection of pancreatic cancer
Masahiro Komoto et al.
CANCER SCIENCE (2009)
An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
Paola Cappello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Regular Dose of Gemcitabine Induces an Increase in CD14+ Monocytes and CD11c+ Dendritic Cells in Patients with Advanced Pancreatic Cancer
Atsuko Soeda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins
Kim D. Pruitt et al.
NUCLEIC ACIDS RESEARCH (2007)
High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients
FH Schmitz-Winnenthal et al.
CANCER RESEARCH (2005)
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
JMD Plate et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
F Baratelli et al.
JOURNAL OF IMMUNOLOGY (2005)
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
Y Oji et al.
CANCER SCIENCE (2004)
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
AK Nowak et al.
JOURNAL OF IMMUNOLOGY (2003)
Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer
Y Hamanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Mucin gene (MUC1) transfected dendritic cells as vaccine:: results of a phase I/II clinical trial
G Pecher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
MA Morse et al.
JOURNAL OF GASTROINTESTINAL CANCER (2002)
The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
A Bairoch et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
